Cetrorelix, a peptide GnRH antagonist, is also shown in clinical studies to produce rapid anti-inflammatory effects in rheumatoid arthritis patients with high gonadotropin levels [111]. The gene discussed is GNRH1; the disease is rheumatoid arthritis.